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• Skeletal muscle displays a high level of plasticity, allowing it 
to adapt to functional changes following mechanical load or 
injury1,2,3
• Skeletal muscle homeostasis is maintained through a 
balance of protein synthesis and degradation, which can be 
effected by changes in activity leading to muscle 
hypertrophy or atrophy4
• Insulin-like growth factor-1 (IGF-1) mediates muscle 
adaptation and begins a cascade involving protein synthesis 
and degradation markers5,6
• The Akt/mTOR pathway contributes to muscle mass 
homeostasis by maintaining the balance between protein 
synthesis and degradation, that when disrupted via activity 
or injury can alter this balance7
• The muscle atrophy-associated genes Atrogin-1 and muscle 
RING-finger protein-1 (MuRF-1) are downstream targets of 
Akt and are upregulated when muscle activity is decreased 
or injured resulting in muscle atrophy4
• Myostatin is present in both developing and adult muscle 
cells and is a negative regulator of muscle mass8
• Cardiotoxin (CTX) is a snake venom that causes complete 
but localized myolysis of targeted skeletal muscle fibers and 
leads to muscle degradation followed by complete 
regeneration9
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• Although there were no significant differences in 
mean body weight, there were significant 
differences in absolute and relative TA muscle 
weight of the CTX-injured TA muscle compared 
to the non-injured Control TA muscle at the 2-, 3-, 
and 4-week time points. There was a significant 
difference in absolute TA muscle weight of the 4-
week CTX-injured TA muscle compared to the 2-
week and 3-week CTX-injured TA muscle.
• There were no significant differences in gene 
expression of Atrogin-1, MuRF-1, or Myostatin 
between the CTX-injured TA muscle and the 
Control TA muscle at the 2-, 3-, and 4-week time 
points when normalized by GAPDH.
• There were no significant differences in protein 
density of Akt between the CTX-injured TA 
muscle and the Control muscle at the 2-, 3-, and 
4-week time points when normalized by β-actin.
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Figure 1. (A) Mean body weight for mice by time point. (B) Absolute and (C) relative muscle weights of Control 
and CTX-injured TA muscles by time point. Values are means ± SEM for 2-week (n=5), 3-week (n=5) and 
4-week (n=5) mice. * significantly different from same time point Con muscles at p<0.05. † significantly different 
from CTX muscles of other time points at p<0.05.
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Figure 2. Mean gene expression of protein degradation markers (A) Atrogin-1, (B) MuRF-1 and (C) Myostatin 
by time point and normalized to reference gene GAPDH. Values are means ± SEM for 2-week (n=4), 3-week 
(n=5) and 4-week (n=5) mice.
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• Extracted protein from muscle *ssue
• Separated proteins by electrophoresis
• Transferred to membrane
• Visualized β-ac*n and Akt proteins by immunohistochemistry and Li-cor
Odyssey Imaging technology
• Analyzed densi*es with ImageJ
qPCR runs of all samples with primers for genes of interest and GAPDH as 
reference
Primer Efficiency Tests
Primer Temperature Op*miza*ons
cDNA Amplifica*on of genes of interest: Atrogin-1, MuRF-1, Myosta*n 
and reference gene: GAPDH
cDNA Synthesis
RNA Isola*on
Purpose: Determine the expression of phosphorylated (active) 
protein isoforms of IGF-1, Akt, and mTOR in CTX-injured and non-
injured TA muscles 
Quantify the mRNA expression of myostatin, atrogin-1, and MuRF-1 
in CTX-injured and non-injured TA muscles 
Hypothesis: I hypothesize that regulation of protein synthesis will be 
affected by CTX. I predict that protein synthesis markers, IGF-1, Akt, 
and mTOR, will be upregulated, leading to increased protein 
synthesis and subsequent muscle hypertrophy. Simultaneously, 
muscle atrophy markers, myostatin, atrogin-1, and MuRF-1 will be 
downregulated, decreasing protein degradation. Together, these two 
shifts in gene expression will give rise to muscle hypertrophy 
following CTX-induced injury.
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Figure 3. (A) Sample western blot of β-ac*n and Akt proteins. (B) Western blot analysis of Akt protein density 
normalized by β-ac*n. Values are means ± SEM for No CTX (n=2), 2-week (n=1), 3-week (n=2) and 4-week 
(n=2) mice.
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